These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9007673)

  • 1. In swine myocardium, the infarct size reduction induced by U-89232 is glibenclamide sensitive: evidence that U-89232 is a cardioselective opener of ATP-sensitive potassium channels.
    Rohmann S; Fuchs C; Schelling P
    J Cardiovasc Pharmacol; 1997 Jan; 29(1):69-74. PubMed ID: 9007673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of ATP-sensitive potassium channels in preconditioning protection.
    Rohmann S; Weygandt H; Schelling P; Kie Soei L; Verdouw PD; Lues I
    Basic Res Cardiol; 1994; 89(6):563-76. PubMed ID: 7702545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of bimakalim (EMD 52692), an opener of ATP sensitive potassium channels, on infarct size, coronary blood flow, regional wall function, and oxygen consumption in swine.
    Rohmann S; Weygandt H; Schelling P; Soei LK; Becker KH; Verdouw PD; Lues I; Häusler G
    Cardiovasc Res; 1994 Jun; 28(6):858-63. PubMed ID: 7923292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardioprotective profile of the cardiac-selective ATP-sensitive potassium channel opener BMS-180448.
    Grover GJ; McCullough JR; D'Alonzo AJ; Sargent CA; Atwal KS
    J Cardiovasc Pharmacol; 1995 Jan; 25(1):40-50. PubMed ID: 7723352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the KATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs.
    Yao Z; Gross GJ
    Circulation; 1994 Apr; 89(4):1769-75. PubMed ID: 8149542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bimakalim, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release, and neutrophil function in dogs.
    Mizumura T; Nithipatikom K; Gross GJ
    Circulation; 1995 Sep; 92(5):1236-45. PubMed ID: 7648671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KR-31762, a novel KATP channel opener, exerts cardioprotective effects by opening SarcKATP channels in rat models of ischemia/reperfusion-induced heart injury.
    Lee SH; Yang MK; Lim JH; Seo HW; Yi KY; Yoo SE; Lee BH; Won HS; Lee CS; Choi WS; Shin HS
    Arch Pharm Res; 2008 Apr; 31(4):482-9. PubMed ID: 18449506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardioprotection with U-89232 is not reversible with glibenclamide: evidence of a novel anti-ischemic agent derived from cromakalim.
    Toombs CF; Moore TL; Shebuski RJ
    Pharmacology; 1994 Aug; 49(2):96-104. PubMed ID: 7972326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of ischaemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist sodium 5-hydroxydecanoate.
    Auchampach JA; Grover GJ; Gross GJ
    Cardiovasc Res; 1992 Nov; 26(11):1054-62. PubMed ID: 1291082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infarct size-reducing effect of nicorandil is mediated by the KATP channel but not by its nitrate-like properties in dogs.
    Mizumura T; Nithipatikom K; Gross GJ
    Cardiovasc Res; 1996 Aug; 32(2):274-85. PubMed ID: 8796114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of a newly synthesized ATP-sensitive potassium channel opener, MJ-355, on blood pressure and myocardial ischemia-reperfusion injury in rats.
    Lee YM; Peng YY; Sheu JR; Cheng CY; Yen MH
    Jpn J Pharmacol; 1999 Oct; 81(2):185-93. PubMed ID: 10591476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KATP channels and memory of ischemic preconditioning in dogs: synergism between adenosine and KATP channels.
    Yao Z; Mizumura T; Mei DA; Gross GJ
    Am J Physiol; 1997 Jan; 272(1 Pt 2):H334-42. PubMed ID: 9038954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs.
    Gross GJ; Auchampach JA
    Circ Res; 1992 Feb; 70(2):223-33. PubMed ID: 1310443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limitation of myocardial injury with the potassium channel opener cromakalim and the nonvasoactive analog U-89,232: vascular vs. cardiac actions in vitro and in vivo.
    Toombs CF; Norman NR; Groppi VE; Lee KS; Gadwood RC; Shebuski RJ
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1261-8. PubMed ID: 1469632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial ischemia/reperfusion protection using monophosphoryl lipid A is abrogated by the ATP-sensitive potassium channel blocker, glibenclamide.
    Elliott GT; Comerford ML; Smith JR; Zhao L
    Cardiovasc Res; 1996 Dec; 32(6):1071-80. PubMed ID: 9015409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KATP channel modulation in working rat hearts with coronary occlusion: effects of cromakalim, cicletanine, and glibenclamide.
    Ferdinandy P; Szilvássy Z; Droy-Lefaix MT; Tarrade T; Koltai M
    Cardiovasc Res; 1995 Nov; 30(5):781-7. PubMed ID: 8595627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection from ischaemic-reperfusion injury with adenosine pretreatment is reversed by inhibition of ATP sensitive potassium channels.
    Toombs CF; McGee DS; Johnston WE; Vinten-Johansen J
    Cardiovasc Res; 1993 Apr; 27(4):623-9. PubMed ID: 8324796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of adenosine triphosphate-sensitive potassium channels eliminates isoflurane-induced coronary artery vasodilation.
    Cason BA; Shubayev I; Hickey RF
    Anesthesiology; 1994 Nov; 81(5):1245-55; discussion 27A-28A. PubMed ID: 7978484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine triphosphate-sensitive potassium channel blocking agent ameliorates, but the opening agent aggravates, ischemia/reperfusion-induced injury. Heart function studies in nonfibrillating isolated hearts.
    Tosaki A; Hellegouarch A
    J Am Coll Cardiol; 1994 Feb; 23(2):487-96. PubMed ID: 8294705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of responses to cromakalim and pinacidil in smooth and cardiac muscle by use of selective antagonists.
    McPherson GA; Angus JA
    Br J Pharmacol; 1990 Jun; 100(2):201-6. PubMed ID: 2116201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.